MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Longitudinal Analysis of BRAIN test in isolated REM sleep behaviour disorder with and without hyposmia.

    H. Chohan, T. Tocino, L. Pérez-Carbonell, G. Leschziner, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess motor dysfunction in individuals with polysomnography (PSG)-confirmed isolated REM Sleep Behaviour Disorder (iRBD), self-reported RBD (sRBD), and sRBD with smell loss (hyposmia).…
  • 2025 International Congress

    P2P Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Design and Statistical Considerations

    T. Simuni, C. Coffey, A. Siderowf, C. Tanner, M. Brumm, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, C. Allen-Savietta, B. Wendelberger, A. Crawford, T. Tropea, K. Fabrizio, H. Whalen, K. Marek (Chicago, USA)

    Objective: To describe the study design and timeline of a platform interventional study in Neuronal α-Synuclein Disease (NSD). Background: The recent description of the biological…
  • 2025 International Congress

    The Benefits of Whole-Body Electro Muscle Stimulation (WB-EMS) in a patient with Parkinson’s Disease

    N. Duff, C. Cawood, M. Noble (Parktown, South Africa)

    Objective: To determine the motor and non-motor benefits of WB-EMS in a patient with Parkinson’s disease Background: Parkinson’s disease causes both motor and non-motor symptoms.…
  • 2025 International Congress

    Comparative efficacy of opicapone and entacapone in the management of motor fluctuations in Parkinson’s disease

    S. Isaacson, F. Amjad, S. Thakkar, D. Martins, H. Brigas, G. Banisadr, S. Fisher (Boca Raton, USA)

    Objective: To compare the clinical efficacy of two catechol-O-methyltransferase (COMT) inhibitors, opicapone (OPC) and entacapone (ENT). Background: OPC and ENT are used as adjunctive therapy…
  • 2025 International Congress

    GT-02287 in Parkinson’s Disease: Interim Data from a Phase 1b Study

    R. Pozzi, T. Ignoni, M. Bosetti, M. Desciscio, A. Evans, V. Fung, A. Lehn, V. Miller, M. Rentería, R. Schwartz, D. Thyagarajan, S. Tisch, J. Taylor, J. Hannestad (Lugano, Switzerland)

    Objective: To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the brain-penetrant glucocerebrosidase (GCase) modulator GT-02287 in people with Parkinson’s disease with and without a…
  • 2025 International Congress

    Improvement of Freezing of Gait with Personalized Rhythmic Auditory Stimulation in Parkinson’s Disease

    CH. Tsai, MC. Tsai, BL. Liu, KY. Hung, YK. Sek, HK. Chen, HC. Huang, MK. Lu, JR. Duann (Taichung, Taiwan)

    Objective: To determine if different types of personalized music rhythmic auditory stimulation (RAS) training can improve gait control in Parkinson's Disease (PD) patients with freezing…
  • 2025 International Congress

    Efficacy and Safety of IPX203 and Levodopa-Carbidopa Intestinal Gel (LCIG) Compared to Immediate-Release Carbidopa-Levodopa in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    M. Mustafa, A. Abunamoos, Y. Aljazi, F. Alnajjar, A. Sa’D, M. Alghaniem, K. Abuhananeh (Amman, Jordan)

    Objective: To conduct the efficacy and safety of IPX203, an extended-release carbidopa-levodopa formulation, and LCIG, a continuous levodopa infusion, compared to Immediate-Release Carbidopa-Levodopa (IR CD-LD)…
  • 2025 International Congress

    Effect of Reaction Oriented Training on Postural Stability and Reaction Time in Parkinsons’s Disease

    M. Salamci, A. Guclu-Gunduz, C. Ozkul, R. Yılmaz, M. Akbostancı (Ankara, Turkey)

    Objective: This study aimed to examine the effect of reaction-oriented training (ROT), a novel rehabilitation approach developed for people with Parkinson's disease (pwPD), on postural…
  • 2025 International Congress

    Correlations of catecholamine metabolites and alpha-synuclein by nigral stimulation in Parkinson’s disease model rat

    T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to clarify the effects of substantia nigra (SN) stimulation on catecholamine levels and α-synuclein in PD model rats. Background: Catecholaminergic neurons are…
  • 2025 International Congress

    A retrospective study on thyroid dysfunction mimicking Parkinsonian symptoms

    D. Mukhammedaminova, L. Kenjaeva (Tashkent, Uzbekistan)

    Objective: This retrospective study analyzes outcomes of nine patients (three females, six males) admitted to the endocrinology department from 2020 to 2024. Initially diagnosed with…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley